Antonino Amato - Publications

Soluble Fas Ligand, an overlooked target of therapy in dermatological and non-dermatological conditions.

Journal: The Journal of dermatological treatment

Published: March 02, 2026

Treatment of pemphigus and other neglected skin conditions with PC111, a human anti-Fas Ligand monoclonal antibody: a potential disease modifier.

Journal: The Journal of dermatological treatment

Published: July 02, 2025

Design and validation of an integrated reference dosimetry and monitoring system for ultra-high dose-rate proton beams ranging from 20 Gy/s to 230 Gy/s.

Journal: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)

Published: March 12, 2025

Advancements in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Treatment: Utilizing Fas-FasL Inhibition to Target Cell Death Signaling Pathways for Practical Human Application.

Journal: The Journal of investigative dermatology

Published: June 25, 2024

Corrigendum: Blocking soluble Fas Ligand ameliorates pemphigus: PC111 efficacy in ex-vivo human pemphigus models.

Journal: Frontiers in immunology

Published: October 31, 2023

Blocking soluble Fas Ligand ameliorates pemphigus: PC111 efficacy in ex-vivo human pemphigus models.

Journal: Frontiers in immunology

Published: March 24, 2023

In Vivo Models for the Performance and Safety of BAT-90, a Novel 90-Yttrium-based Internal Radiotherapy Platform.

Journal: In vivo (Athens, Greece)

Published: June 30, 2022

Pilot clinical study on the prevention of complications after lung biopsy by the MIPP kit PNX device.

Journal: Translational cancer research

Published: April 29, 2022

A Novel Injectable Hydrogel Matrix Loaded With 90Y Microspheres for the Treatment of Solid Tumors.

Journal: Anticancer research

Published: November 16, 2021